FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction
Wu, D-W ; Lee, M-C ; Hsu, N-Y ; Wu, T-C ; Wu, J-Y ; Wang, Y-C ; Cheng, Y-W ; Chen, C-Y ; Lee, H
Oncogene, 2015-05, Vol.34 (19), p.2505-2515 [Periódico revisado por pares]England: Nature Publishing Group
Texto completo disponível